Age, Biography and Wiki

Archie Fraser (Archibald Hugh Fraser) was born on 10 April, 1959 in Scotland, is an Archibald Hugh Fraser is based business executive. Discover Archie Fraser's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 64 years old?

Popular As Archibald Hugh Fraser
Occupation N/A
Age 64 years old
Zodiac Sign Aries
Born 10 April, 1959
Birthday 10 April
Birthplace Scotland
Nationality Scotland

We recommend you to check the complete list of Famous People born on 10 April. He is a member of famous business executive with the age 64 years old group.

Archie Fraser Height, Weight & Measurements

At 64 years old, Archie Fraser height not available right now. We will update Archie Fraser's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Archie Fraser Net Worth

His net worth has been growing significantly in 2023-2024. So, how much is Archie Fraser worth at the age of 64 years old? Archie Fraser’s income source is mostly from being a successful business executive. He is from Scotland. We have estimated Archie Fraser's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income business executive

Archie Fraser Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia Archie Fraser Wikipedia
Imdb

Timeline

1959

Archibald Hugh Fraser is an Australian based business executive, was born 10 April 1959 in Scotland.

1980

Fraser played professional association football for Greenock Morton before moving to Australia in 1980 to play in Brisbane.

1996

From 1996 to 1999 Fraser was a senior executive with global recruitment company Adecco as A & NZ CEO.

1999

In 1999, he joined as a partner and CEO of Melbourne-based HR consulting practice Hamilton Watts International (HWI) with operations in Australia, Singapore, Malaysia and the United Kingdom.

2000

In July 2000 the NYSE listed Cendant Corporation acquired HWI.

Following the acquisition, Fraser joined Cendant Mobility as Managing Director Asia Pacific, reporting to the US as Australian director.

2005

Fraser was appointed to the executive of AFL Club St Kilda FC in 2005 and appointed as the Saints CEO in 2006 where he led the club through a period of significant restructure, improvement and change, including the appointment of a new Senior Coach Ross Lyon and the transition to the Greg Westaway leadership and Footy First Board.

2006

Both events were significant milestones in the stability and direction of the Saints both on and off the field from 2006 to 2010.

Fraser joined the St Kilda Football Club in 2005 after consulting assignments with the club over the previous four years before being appointed CEO on 1 July 2006.

One of Fraser's legacies at the Saints was managing the club's move and negotiating the right deal for their new fully funded training and administration facilities to Frankston.

This facility and the overall deal was rated as the top facility development project by the AFL with the lowest cost to the club over a 10- and 20-year projection period compared to all other AFL facility projects at the time.

The AFL rated the Saints deal over a 20-year period as $6 m better than the average and $10 m better than the most costly club deal.

The deal however, wasn't without its drawbacks.

2009

The club played in both the 2009 & 2010 Grand Finals.

In 2009 Fraser was appointed as head of the Hyundai A-League.

Despite speculation linking Fraser with a move back to the Gold Coast, as the new CEO of the AFL Club GC17, he repeatedly stated his loyalty to St Kilda., and eventually left the sport of AFL in 2009.

In March 2009, Fraser joined Football Federation Australia as the Head Of The A-League.

2010

Fraser announced his resignation as head of the Hyundai A-League in 2010 to move back into his consulting business which has a focus on medi tech, sports tech, commercialisation and strategy.

He remained in the position until June 2010.

2011

Nick Riewoldt, one of St.Kilda's most lauded players, is on record as saying that the club's move to Seaford in 2011 "crushed" the playing group.

2012

In 2012 he took up a position with Clive Palmer's 'rebel' organisation Football Australia following the cancellation of Palmer's license to run the Gold Coast United FC A-League club.

Football Australia was only active for a short period of time in 2012 before it became defunct, this rebel organisation should not be confused with the FFA despite that organisation renaming itself to Football Australia in 2020.

2016

In 2016 Fraser was appointed as CEO to turn around the ASX listed Meditech company Optiscan Ltd (OIL) where between 2016 and 2018 he successfully increased the market capitalisation from $4 m to $55 million and the share price from 2c to a 52-week high of 13c.

During this time Optiscan collaborated with Carl Zeiss Meditec to deliver a breakthrough product to the Neurosurgery market following the achievement of the required QA, CE and FDA testing process.

2019

He began an independent sports consulting firm after leaving and continued in that role until joining newly formed A-League club Macarthur FC in 2019.

He stayed at the new football club for 6 months then left after initial owner Lang Walker sold his position to another board member.

After leaving the sports sector, he began working for Nico.lab, a Dutch health company using computer algorithms to detect and diagnose stroke in humans.